German acromegaly patients interim results from the International Observational Acromegaly Study on impact of sandostatin LAR OASIS

被引：0
|
作者：
Petersenn, S.
Etzrodt, H.
Sievers, C.
Droste, M.
Wallaschofski, H.
Decroix, L.
Stalla, G. K.
机构：
[1] Univ Klinikum Essen, Essen, Germany
[2] Max Planck Inst Psychiat, Dept Neuroendocrinol, D-80804 Munich, Germany
[3] Univ Klinikum Greifswald, Greifswald, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
来源：
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2007年 / 115卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P7
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [31] Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
    Neggers, Sebastian J. C. M. M.
    Pronin, Vyacheslav
    Balcere, Inga
    Lee, Moon-Kyu
    Rozhinskaya, Liudmila
    Bronstein, Marcello D.
    Gadelha, Monica R.
    Maisonobe, Pascal
    Sert, Caroline
    van der Lely, Aart Jan
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (03) : 313 - 323
  • [32] Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study
    Colao, Annamaria
    Cappabianca, Paolo
    Caron, Philippe
    De Menis, Ernesto
    Farrall, Andrew J.
    Gadelha, Monica R.
    Hmissi, Abdel
    Rees, Aled
    Reincke, Martin
    Safari, Mitra
    T'Sjoen, Guy
    Bouterfa, Hakim
    Cuneo, Ross C.
    CLINICAL ENDOCRINOLOGY, 2009, 70 (05) : 757 - 768
  • [33] Pharmacokinetics, Pharmacodynamics, and Safety of Pasireotide LAR in Patients With Acromegaly: A Randomized, Multicenter, Open-Label, Phase I Study
    Petersenn, Stephan
    Bollerslev, Jens
    Arafat, Ayman M.
    Schopohl, Jochen
    Serri, Omar
    Katznelson, Laurence
    Lasher, Janet
    Hughes, Gareth
    Hu, Ke
    Shen, George
    Resendiz, Karina Hermosillo
    Giannone, Vanessa
    Beckers, Albert
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (11): : 1308 - 1317
  • [34] Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era
    Andrea Giustina
    Ewen Legg
    Bruno Mario Cesana
    Stefano Frara
    Pietro Mortini
    Maria Fleseriu
    Endocrine, 2021, 71 : 273 - 280
  • [35] Quality of life in patients with acromegaly receiving lanreotide autogel: a real-world observational study
    Bolanowski, Marek
    Hubalewska-Dydejczyk, Alicja
    Kos-Kudla, Beata
    Ruchala, Marek
    Witek, Przemyslaw
    Zgliczynski, Wojciech
    Houchard, Aude
    Bartmanska, Marta
    ENDOKRYNOLOGIA POLSKA, 2021, 72 (05) : 512 - 519
  • [36] Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era
    Giustina, Andrea
    Legg, Ewen
    Cesana, Bruno Mario
    Frara, Stefano
    Mortini, Pietro
    Fleseriu, Maria
    ENDOCRINE, 2021, 71 (02) : 273 - 280
  • [37] IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE IN ACROMEGALY WITH PASIREOTIDE LAR AND OCTREOTIDE LAR: RESULTS FROM A LARGE, RANDOMIZED, DOUBLE-BLIND PHASE III TRIAL
    Badia, X.
    Forsythe, A.
    Nelson, L. M.
    Coles, T. M.
    Mcleod, L. D.
    Webb, S. M.
    VALUE IN HEALTH, 2012, 15 (07) : A505 - A505
  • [38] Prevalence of thyroid diseases in patients with acromegaly: results of an Italian Multi-center Study
    Gasperi, M
    Martino, E
    Manetti, L
    Arosio, M
    Porretti, S
    Faglia, G
    Mariotti, S
    Colao, AM
    Lombardi, G
    Baldelli, R
    Camanni, F
    Liuzzi, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (03) : 240 - 245
  • [39] Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
    Buchfelder, M.
    Weigel, D.
    Droste, M.
    Mann, K.
    Saller, B.
    Bruebach, K.
    Stalla, G. K.
    Bidlingmaier, M.
    Strasburger, C. J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (01) : 27 - 35
  • [40] Prevalence of thyroid diseases in patients with acromegaly: results of an Italian Multi-center Study
    M. Gasperi
    E. Martino
    L. Manetti
    M. Arosio
    S. Porretti
    G. Faglia
    S. Mariotti
    A. M. Colao
    G. Lombardi
    R. Baldelli
    F. Camanni
    A. Liuzzi
    Journal of Endocrinological Investigation, 2002, 25 : 240 - 245
12345